264 related articles for article (PubMed ID: 24144649)
1. Interferon regulatory factor 9 protects against cardiac hypertrophy by targeting myocardin.
Jiang DS; Luo YX; Zhang R; Zhang XD; Chen HZ; Zhang Y; Chen K; Zhang SM; Fan GC; Liu PP; Liu DP; Li H
Hypertension; 2014 Jan; 63(1):119-27. PubMed ID: 24144649
[TBL] [Abstract][Full Text] [Related]
2. Ca²⁺ signal-induced cardiomyocyte hypertrophy through activation of myocardin.
Li M; Wang N; Gong HQ; Li WZ; Liao XH; Yang XL; He HP; Cao DS; Zhang TC
Gene; 2015 Feb; 557(1):43-51. PubMed ID: 25485719
[TBL] [Abstract][Full Text] [Related]
3. Interferon regulatory factor 1 is required for cardiac remodeling in response to pressure overload.
Jiang DS; Li L; Huang L; Gong J; Xia H; Liu X; Wan N; Wei X; Zhu X; Chen Y; Chen X; Zhang XD; Li H
Hypertension; 2014 Jul; 64(1):77-86. PubMed ID: 24732887
[TBL] [Abstract][Full Text] [Related]
4. Myocardin induces cardiomyocyte hypertrophy.
Xing W; Zhang TC; Cao D; Wang Z; Antos CL; Li S; Wang Y; Olson EN; Wang DZ
Circ Res; 2006 Apr; 98(8):1089-97. PubMed ID: 16556869
[TBL] [Abstract][Full Text] [Related]
5. The mechanism of myocardial hypertrophy regulated by the interaction between mhrt and myocardin.
Luo Y; Xu Y; Liang C; Xing W; Zhang T
Cell Signal; 2018 Mar; 43():11-20. PubMed ID: 29199045
[TBL] [Abstract][Full Text] [Related]
6. The synergistic effects of cytomegalovirus IE2 and myocardin on cardiomyocyte hypertrophy.
Zhou J; Liao XH; Wu C; Li J; Xiao R; Cheng C; Wang N; Cao D; Zhang TC
FEBS Lett; 2011 Apr; 585(7):1082-8. PubMed ID: 21385583
[TBL] [Abstract][Full Text] [Related]
7. Caspase recruitment domain 6 protects against cardiac hypertrophy in response to pressure overload.
Li L; Chen W; Zhu Y; Wang X; Jiang DS; Huang F; Wang L; Xiang F; Qin W; Wang Q; Zhang R; Zhu X; Li H; Chen X
Hypertension; 2014 Jul; 64(1):94-102. PubMed ID: 24777975
[TBL] [Abstract][Full Text] [Related]
8. miR-9 and NFATc3 regulate myocardin in cardiac hypertrophy.
Wang K; Long B; Zhou J; Li PF
J Biol Chem; 2010 Apr; 285(16):11903-12. PubMed ID: 20177053
[TBL] [Abstract][Full Text] [Related]
9. Possible mechanism of GATA4 inhibiting myocardin activity during cardiac hypertrophy.
Xu Y; Liang C; Luo Y; Xing W; Zhang T
J Cell Biochem; 2019 Jun; 120(6):9047-9055. PubMed ID: 30582211
[TBL] [Abstract][Full Text] [Related]
10. Co-activation of nuclear factor-κB and myocardin/serum response factor conveys the hypertrophy signal of high insulin levels in cardiac myoblasts.
Madonna R; Geng YJ; Bolli R; Rokosh G; Ferdinandy P; Patterson C; De Caterina R
J Biol Chem; 2014 Jul; 289(28):19585-98. PubMed ID: 24855642
[TBL] [Abstract][Full Text] [Related]
11. Interferon regulatory factor 9 is an essential mediator of heart dysfunction and cell death following myocardial ischemia/reperfusion injury.
Zhang Y; Liu X; She ZG; Jiang DS; Wan N; Xia H; Zhu XH; Wei X; Zhang XD; Li H
Basic Res Cardiol; 2014; 109(5):434. PubMed ID: 25150882
[TBL] [Abstract][Full Text] [Related]
12. NF-κB (p65) negatively regulates myocardin-induced cardiomyocyte hypertrophy through multiple mechanisms.
Liao XH; Wang N; Zhao DW; Zheng DL; Zheng L; Xing WJ; Zhou H; Cao DS; Zhang TC
Cell Signal; 2014 Dec; 26(12):2738-48. PubMed ID: 25152367
[TBL] [Abstract][Full Text] [Related]
13. Glycogen synthase kinase 3beta inhibits myocardin-dependent transcription and hypertrophy induction through site-specific phosphorylation.
Badorff C; Seeger FH; Zeiher AM; Dimmeler S
Circ Res; 2005 Sep; 97(7):645-54. PubMed ID: 16141410
[TBL] [Abstract][Full Text] [Related]
14. Protein kinase Cα inhibits myocardin-induced cardiomyocyte hypertrophy through the promotion of myocardin phosphorylation.
Li W; Wang N; Li M; Gong H; Liao X; Yang X; Zhang T
Acta Biochim Biophys Sin (Shanghai); 2015 Sep; 47(9):687-95. PubMed ID: 26206583
[TBL] [Abstract][Full Text] [Related]
15. Control of Pathological Cardiac Hypertrophy by Transcriptional Corepressor IRF2BP2 (Interferon Regulatory Factor-2 Binding Protein 2).
Fang J; Li T; Zhu X; Deng KQ; Ji YX; Fang C; Zhang XJ; Guo JH; Zhang P; Li H; Wei X
Hypertension; 2017 Sep; 70(3):515-523. PubMed ID: 28716987
[TBL] [Abstract][Full Text] [Related]
16. Kruppel-like factor 4 protein regulates isoproterenol-induced cardiac hypertrophy by modulating myocardin expression and activity.
Yoshida T; Yamashita M; Horimai C; Hayashi M
J Biol Chem; 2014 Sep; 289(38):26107-26118. PubMed ID: 25100730
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II and the ERK pathway mediate the induction of myocardin by hypoxia in cultured rat neonatal cardiomyocytes.
Chiu CZ; Wang BW; Chung TH; Shyu KG
Clin Sci (Lond); 2010 Jun; 119(7):273-82. PubMed ID: 20446923
[TBL] [Abstract][Full Text] [Related]
18. Role of interferon regulatory factor 4 in the regulation of pathological cardiac hypertrophy.
Jiang DS; Bian ZY; Zhang Y; Zhang SM; Liu Y; Zhang R; Chen Y; Yang Q; Zhang XD; Fan GC; Li H
Hypertension; 2013 Jun; 61(6):1193-202. PubMed ID: 23589561
[TBL] [Abstract][Full Text] [Related]
19. Cardiac-Specific EPI64C Blunts Pressure Overload-Induced Cardiac Hypertrophy.
Zhu X; Fang J; Gong J; Guo JH; Zhao GN; Ji YX; Liu HY; Wei X; Li H
Hypertension; 2016 May; 67(5):866-77. PubMed ID: 27021007
[TBL] [Abstract][Full Text] [Related]
20. Targeted disruption of Hspa4 gene leads to cardiac hypertrophy and fibrosis.
Mohamed BA; Barakat AZ; Zimmermann WH; Bittner RE; Mühlfeld C; Hünlich M; Engel W; Maier LS; Adham IM
J Mol Cell Cardiol; 2012 Oct; 53(4):459-68. PubMed ID: 22884543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
